Currents in contemporary ethics

Journal of Law, Medicine and Ethics

Volumn 32, Issue 2, 2004, Pages 365-368

  Caulfield, Timothy ^a,b   Lemmens, Trudo ^c,d   Kinsella, Douglas ^e,f   McDonald, Michael ^g,h  

^a Health Law and Policy   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d Alberta's Res Ethics Rev Committee ^*  (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f Institute for Advanced Studies   (Canada)

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^h CANADIAN INSTITUTES OF HEALTH RESEARCH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ETHICS; GOVERNMENT; HUMAN; PHYSICIAN; POLICY; PROFESSIONAL PRACTICE; REVIEW; ARTICLE; BIOETHICS; BIOMEDICAL AND BEHAVIORAL RESEARCH; CANADA; CANADIAN MEDICAL ASSOCIATION; DOCTOR PATIENT RELATION; MEDICAL SOCIETY; PROFESSIONAL STANDARD; PUBLIC RELATIONS; RESEARCH ETHICS;

BIOMEDICAL AND BEHAVIORAL RESEARCH; CANADIAN MEDICAL ASSOCIATION;

BIOETHICAL ISSUES; CANADA; ETHICS COMMITTEES, RESEARCH; ETHICS, RESEARCH; HUMANS; INTERPROFESSIONAL RELATIONS; PHYSICIAN-PATIENT RELATIONS; SOCIETIES, MEDICAL;

EID: 4644220405     PISSN: 10731105     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1748-720X.2004.tb00483.x     Document Type: Review

References (42)

1. K. Morin et al., "Managing Conflicts of Interest in the Conduct of Clinical Trials" JAMA 287 (2002): 78-84.
2. T. Lemmens and P.B. Miller, "The Human Subjects Trade: Ethical and Legal Issues Surrounding Recruitment Incentives" JLME 31(2003): 398-418.
3. Editorial, "The Doctor's Choice" The Globe and Mail (24 July 2003): A12.
4. E. DeRenzo, "Coercion in the Recruitment and Retention of Human Research Subjects, Pharmaceutical Industry Payments to Physician-Investigators and the Moral Courage of the IRB," IRB 22 (2000): 1-5; R. Rutherford, "Potential Problems with Industry-Supported Clinical Research," Journal of Vascular Surgery 31 (2000): 1066-76.
5. E. DeRenzo, "Coercion in the Recruitment and Retention of Human Research Subjects, Pharmaceutical Industry Payments to Physician-Investigators and the Moral Courage of the IRB," IRB 22 (2000): 1-5; R. Rutherford, "Potential Problems with Industry-Supported Clinical Research," Journal of Vascular Surgery 31 (2000): 1066-76.
6. T. Caulfield and G. Griener, "Conflicts of Interest in Clinical Research: Addressing the Issue of Physician Remuneration, "JLME 30 (2002): 305-308.
7. J. Goldner, "Dealing with Conflicts of Interest in Biomedical Research: IRB Oversight as the Nest Best Solution to the Abolitionist Approach," JLME 28 (2000): 379-404.
8. E. M. Meslin and M. McDonald, "Research Ethics as Social Policy: Some Lessons from Experiences in Canada and the United States," The Tocqueville Review/la Revue Tocqueville (forthcoming).
9. Canadian Medical Association, Code of Ethics 〈www.cma.ca/commonPage. do?pageId=/staticContent/HTML/NO12/where_we_stand/code.htm〉 (last visited March 23, 2004).
10. Manitoba College of Physicians and Surgeons, "Conflict of Interest: Relationship with the Pharmaceutical Industry (106 Guidelines) 〈www.umanitoba.ca/colleges/cps/Guidelines_and_statements/106.html〉 (last visited March 23, 2004).
11. College of Physicians and Surgeons of New Brunswick, Code of Ethics 〈www.cpnsb.org/english/code-of-ethics.html〉 (last visited March 23, 2004).
12. College of Physicians and Surgeons of Ontario, "MDs Relations with Drug Companies" 〈www.cpso.on.ca/Policies/drug_relation.htm〉 (last visited March 23, 2004).
13. College of Physicians and Surgeons of Alberta, Bylaws 〈www.cpsa.ab.ca/aboutus/attachments/2003Bylaws.doc〉 (last visited March 23, 2004).
14. T. Lemmens and B. Freedman, "Ethics Review for Sale? Conflicts of Interest and Commercial Research Review Boards," Milbank Quarterly 78 (2000): 547-83.
15. L. McNamara, E. Nelson and B. Windwick, "Regulation of Health Care Professionals" in J. Downie, T. Caulfield and C. Flood, Canadian Health Law and Policy (Toronto: Butterworths, 2002).
16. Medical Practitioners Act, R.S.B.C. 1996, Ch 285, s. 3(1).
17. Medical Act, R.S.P.E.I. 1988, c. M-5, s. 3.
18. Health Professions Act, S.A. 2002, c. H-7. Though this law has been enacted, it will not apply to Alberta physicians until the relevant regulations have been developed and implemented.
19. See Medical Act, S.N.S. 1995-96, c. 10 (amended 1998 c.31), s. 4(3); Medical Act, S.N.B. 1981, c. 87, s. 5(3); College of Physicians and Surgeons of Saskatchewan, policy e-2, public protection, 〈www. quadrant.net/cpss/who. html〉 (last visited March 23, 2004).
20. See Medical Act, S.N.S. 1995-96, c. 10 (amended 1998 c.31), s. 4(3); Medical Act, S.N.B. 1981, c. 87, s. 5(3); College of Physicians and Surgeons of Saskatchewan, policy e-2, public protection, 〈www. quadrant.net/cpss/who. html〉 (last visited March 23, 2004).
21. Caulfield and Griener, supra note 5; Office of Human Research Protection, Draft Interim Guidance, "Financial Relationships in Clinical Trials" (January 10, 2001); US General Accounting Office, Report to Congressional Requesters, NIH Clinical Trials: Various Factors Affect Patient Participation (September 1999) (GAO/HEHS - 99 - 182).
22. Caulfield and Griener, supra note 5; Office of Human Research Protection, Draft Interim Guidance, "Financial Relationships in Clinical Trials" (January 10, 2001); US General Accounting Office, Report to Congressional Requesters, NIH Clinical Trials: Various Factors Affect Patient Participation (September 1999) (GAO/HEHS - 99 - 182).
23. Caulfield and Griener, supra note 5; Office of Human Research Protection, Draft Interim Guidance, "Financial Relationships in Clinical Trials" (January 10, 2001); US General Accounting Office, Report to Congressional Requesters, NIH Clinical Trials: Various Factors Affect Patient Participation (September 1999) (GAO/HEHS - 99 - 182).
24. K. Morin, H. Rakatansky, F. Riddick, et al., "Managing Conflicts of Interest in the Conduct of Clinical Trials," JAMA 278 (2002): 78-84.
25. College of Physicians and Surgeons of British Columbia, "The Role of the College" 〈www.cpsbc.bc.ca/role_of_college.htm〉 (last visited March 23, 2004).
26. Medical Profession Act, R.S.A. 2000, c.M-11, s. 30.
27. Health Professions Act, S.A. 2002, c. H-7.
28. Norberg v. Wynrib (1992) 92 D.L.R. (4th) 449 (S.C.C.).
29. McInerney v. MacDonald (1992), 93 D.L.R. (4th) 449 (S.C.C.).
30. M. Litman and S. Sheremeta, "The Report of the Committee of Inquiry on the Case Involving Dr. Nancy Olivieri: A Fiduciary Law Perspective," Health Law Review 10 (2002): 3-13.
31. See M.A. Rodwin, "Strains in the Fiduciary Metaphor: Divided Physician Loyalties and Obligations in a Changing Health Care System" American Journal of Law and Medicine 21 (1995): 241-257.
32. M. Litman, "Fiduciary Law and ForProfit and Not-For-Profit Health Care" in T. Caulfield and B. von Tigerstrom, Health Care Reform and the Law in Canada (University of Alberta Press, 2002).
33. Lemmens and Freedman, supra note 13.
34. Guerin v. The Queen [1984] 2 S.C.R. 335
35. Litman, supra note 28.
36. F. Miller, "Trusting Doctors: Tricky Business When It Comes To Clinical Research," Boston University Law Review 81 (2001) 423-456.
37. D. Shalala, "Protecting Research Subjects - What must be done," N. Eng. J. Med. 343 (2000): 808-810.
38. Miller, supra note 32: at 439.
39. C. DeAngelis, "Conflict of Interest and the Public Trust,"JAMA 284 (2000): 2237-2238.
40. M. Wynia, et al., "Medical Professionalism in Society," N. End. J. Med. 341 (1999): 12-16.
41. W. May, "The Beleaguered Rulers: The Public Obligation of the Professional," Kennedy Institute of Ethics Journal 2 (1992) 25-41.
42. Tri-Council Policy Statement on Ethical Conduct for Research Involving Humans (Medical Research Council, Ottawa, 1998).